IL122371A0 - Compounds with growth hormone releasing properties - Google Patents
Compounds with growth hormone releasing propertiesInfo
- Publication number
- IL122371A0 IL122371A0 IL12237196A IL12237196A IL122371A0 IL 122371 A0 IL122371 A0 IL 122371A0 IL 12237196 A IL12237196 A IL 12237196A IL 12237196 A IL12237196 A IL 12237196A IL 122371 A0 IL122371 A0 IL 122371A0
- Authority
- IL
- Israel
- Prior art keywords
- compounds
- growth hormone
- hormone releasing
- releasing properties
- properties
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000122 growth hormone Substances 0.000 title 1
- 230000003578 releasing effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK71995 | 1995-06-22 | ||
| DK137195 | 1995-12-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL122371A0 true IL122371A0 (en) | 1998-06-15 |
Family
ID=26064522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12237196A IL122371A0 (en) | 1995-06-22 | 1996-06-19 | Compounds with growth hormone releasing properties |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0833845A1 (cs) |
| KR (1) | KR19990028303A (cs) |
| AU (1) | AU711104B2 (cs) |
| BR (1) | BR9608909A (cs) |
| CA (1) | CA2224434A1 (cs) |
| CZ (1) | CZ287948B6 (cs) |
| HU (1) | HUP9802821A3 (cs) |
| IL (1) | IL122371A0 (cs) |
| NO (1) | NO975992L (cs) |
| PL (1) | PL186520B1 (cs) |
| TW (1) | TW458958B (cs) |
| WO (1) | WO1997000894A1 (cs) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3938797A (en) * | 1996-08-29 | 1998-03-19 | Novo Nordisk A/S | Transdermal delivery of peptides |
| EP1005484A1 (en) | 1997-06-20 | 2000-06-07 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| US6127341A (en) * | 1997-06-20 | 2000-10-03 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| KR100683445B1 (ko) | 1997-08-22 | 2007-02-20 | 가켄 세야쿠 가부시키가이샤 | 신규한 아미드 유도체 |
| HUP0100777A3 (en) | 1998-01-16 | 2001-12-28 | Novo Nordisk As | Tripeptides with growth hormone releasing properties, pharmaceutical compositions comprising thereof and their use |
| US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
| WO1999058505A2 (en) * | 1998-05-12 | 1999-11-18 | Warner-Lambert Company | Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer |
| EP1100824B1 (en) * | 1998-06-30 | 2011-03-02 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| US6919315B1 (en) | 1998-06-30 | 2005-07-19 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| WO2000009537A2 (en) | 1998-08-14 | 2000-02-24 | Administrators Of The Tulane Educational Fund | Compounds having growth hormone releasing activity |
| EP1930021A3 (en) | 1999-02-18 | 2008-06-18 | Kaken Pharmaceutical Co., Ltd. | Novel amide derivatives as growth hormone secretagogues |
| EP1159964B1 (en) | 2000-05-31 | 2009-10-28 | Pfizer Products Inc. | Use of growth hormone secretagogues for stimulating gastrointestinal motility |
| WO2002060859A2 (en) | 2000-12-20 | 2002-08-08 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| AU2002241724A1 (en) | 2000-12-20 | 2002-07-01 | Bristol-Myers Squibb Company | Diamines as modulators of chemokine receptor activity |
| TWI331922B (en) | 2002-08-09 | 2010-10-21 | Ipsen Pharma Sas | Growth hormone releasing peptides |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| EP2258357A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| EP2275096A3 (en) | 2005-08-26 | 2011-07-13 | Braincells, Inc. | Neurogenesis via modulation of the muscarinic receptors |
| CU23558A1 (es) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
| WO2008130464A1 (en) | 2007-02-09 | 2008-10-30 | Tranzyme Pharma, Inc. | Macrocyclic ghrelin receptor modulators and methods of using the same |
| US8466151B2 (en) | 2007-12-26 | 2013-06-18 | Critical Outcome Technologies, Inc. | Compounds and method for treatment of cancer |
| EP2318406B1 (en) | 2008-07-17 | 2016-01-27 | Critical Outcome Technologies, Inc. | Thiosemicarbazone inhibitor compounds and cancer treatment methods |
| CA2999435A1 (en) | 2010-04-01 | 2011-10-06 | Critical Outcome Technologies Inc. | Compounds and method for treatment of hiv |
| WO2013190520A2 (en) | 2012-06-22 | 2013-12-27 | The General Hospital Corporation | Gh-releasing agents in the treatment of vascular stenosis and associated conditions |
| US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
| US20170121385A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5663146A (en) * | 1991-08-22 | 1997-09-02 | Administrators Of The Tulane Educational Fund | Polypeptide analogues having growth hormone releasing activity |
| SG55069A1 (en) * | 1993-12-23 | 1998-12-21 | Novo Nordisk As | Compounds with growth hormone releasing properties |
| US5798337A (en) * | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
-
1996
- 1996-06-19 IL IL12237196A patent/IL122371A0/xx not_active IP Right Cessation
- 1996-06-19 HU HU9802821A patent/HUP9802821A3/hu unknown
- 1996-06-19 KR KR1019970709617A patent/KR19990028303A/ko not_active Ceased
- 1996-06-19 CZ CZ19974081A patent/CZ287948B6/cs not_active IP Right Cessation
- 1996-06-19 AU AU61882/96A patent/AU711104B2/en not_active Ceased
- 1996-06-19 BR BR9608909A patent/BR9608909A/pt not_active Application Discontinuation
- 1996-06-19 WO PCT/DK1996/000266 patent/WO1997000894A1/en not_active Application Discontinuation
- 1996-06-19 PL PL96324200A patent/PL186520B1/pl unknown
- 1996-06-19 EP EP96920742A patent/EP0833845A1/en not_active Withdrawn
- 1996-06-19 CA CA002224434A patent/CA2224434A1/en not_active Abandoned
- 1996-06-28 TW TW085107813A patent/TW458958B/zh not_active IP Right Cessation
-
1997
- 1997-12-19 NO NO975992A patent/NO975992L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0833845A1 (en) | 1998-04-08 |
| JP4173541B2 (ja) | 2008-10-29 |
| NO975992L (no) | 1998-02-20 |
| AU711104B2 (en) | 1999-10-07 |
| TW458958B (en) | 2001-10-11 |
| KR19990028303A (ko) | 1999-04-15 |
| JPH11507928A (ja) | 1999-07-13 |
| AU6188296A (en) | 1997-01-22 |
| BR9608909A (pt) | 1999-03-02 |
| CZ287948B6 (cs) | 2001-03-14 |
| WO1997000894A1 (en) | 1997-01-09 |
| HUP9802821A3 (en) | 2000-03-28 |
| MX9710377A (es) | 1998-03-29 |
| CA2224434A1 (en) | 1997-01-09 |
| PL186520B1 (pl) | 2004-01-30 |
| NO975992D0 (no) | 1997-12-19 |
| PL324200A1 (en) | 1998-05-11 |
| CZ408197A3 (cs) | 1998-05-13 |
| HUP9802821A2 (hu) | 1999-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9802580A3 (en) | Compounds with growth hormone releasing properties | |
| IL122371A0 (en) | Compounds with growth hormone releasing properties | |
| NO973446L (no) | Forbindelser med veksthormonfrigjörende egenskaper | |
| EP0741578A4 (en) | HUMAN GROWTH HORMONE | |
| ZA985278B (en) | Compounds with growth hormone releasing properties | |
| AU2382097A (en) | Compounds with growth hormone releasing properties | |
| ZA961007B (en) | Compounds with growth hormone releasing properties | |
| ZA961008B (en) | Compounds with growth hormone releasing properties | |
| GB9415958D0 (en) | Anglers aid | |
| ZA9610775B (en) | Compounds with growth hormone releasing properties | |
| ZA96544B (en) | Compounds with growth hormone releasing properties | |
| ZA965279B (en) | Compounds with growth hormone releasing properties | |
| ZA9410262B (en) | Compounds with growth hormone releasing properties | |
| ZA9410261B (en) | Compounds with growth hormone releasing properties | |
| ZA973483B (en) | Compounds with growth hormone releasing properties. | |
| GB9225928D0 (en) | Growth factor | |
| GB9424232D0 (en) | Growth factor expression | |
| EP0891372A4 (en) | HTTR36 GROWTH FACTOR | |
| KR0108925Y1 (en) | Sinker | |
| KR0110391Y1 (en) | Supprort for fishing-rods | |
| HU867U (en) | Tackle | |
| ZA99238B (en) | Compounds with growth hormone releasing properties. | |
| ZA200005820B (en) | Compounds with growth hormone releasing properties. | |
| PL102999U1 (en) | Small umbrella for anglers | |
| GB9514254D0 (en) | Float-ledger fishing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |